IlluminOss Medical Announces the Enrollment of First Patient in Proximal Humerus Fracture Repair Trial at Albert Schweitzer Hospital
Light Fix Proximal Humerus Trial Led by Dr. Paul Vegt to Apply IlluminOss’ PatientConforming Implant Technology to Fragility Fractures; First use of New Latitude Radiopaque Markings
East Providence, RI/Dordrecht, Netherlands, (March 24, 2015) – IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that the first patient has been enrolled at Albert Schweitzer Hospital in the Netherlands as part of its EU Light fix Proximal Humerus Fracture Repair Trial for the treatment of osteoporotic and fragility fractures. The trial at Albert Schweitzer Hospital is being led by Dr. Paul Vegt, M.D., Ph.D, and is an expansion of IlluminOss’ technology in to the treatment of osteoporotic and fragility fractures most common in the elderly.
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.